{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T14:22:51Z","timestamp":1792419771610,"version":"4.5.0"},"reference-count":172,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>\n                    Pancreatic cancer (PC) represents one of the most formidable challenges in oncology, characterized by its asymptomatic onset, delayed clinical detection, and dismal prognosis. Among pancreatic neoplasms, pancreatic ductal adenocarcinoma (PDAC) accounts for over 90% of cases and remains the most aggressive form, driven by late diagnosis, intrinsic chemoresistance, and a profoundly immunosuppressive tumor microenvironment. Recent advances have reframed the human microbiome not as a passive bystander but as an active architect of pancreatic tumor biology. This review delineates the mechanistic axes through which microbial ecosystems orchestrate PDAC progression across four key anatomical niches-gastrointestinal, oral, urogenital, and intrapancreatic. We elucidate how microbial dysbiosis fosters oncogenesis through immune evasion, metabolic reprogramming, and chronic inflammation, implicating specific taxa such as\n                    <jats:italic>Fusobacterium nucleatum<\/jats:italic>\n                    ,\n                    <jats:italic>Malassezia<\/jats:italic>\n                    spp., and\n                    <jats:italic>Porphyromonas gingivalis<\/jats:italic>\n                    in immune suppression and chemoresistance. Microbial enzymatic inactivation of gemcitabine and modulation of cytokine networks further underscore the microbiome\u2019s pivotal role in therapeutic failure. Conversely, commensal and probiotic species may potentiate immunosurveillance and enhance treatment efficacy. This review also explores microbiota-derived biomarkers for early detection and the translational promise of microbiome-targeted interventions, including fecal microbiota transplantation, probiotics, and selective antibiotics. By decoding the microbial blueprint of PC, we propose a paradigm in which the microbiome emerges as both a biomarker and a therapeutic axis, offering novel avenues for precision oncology. Furthermore, this integrative synthesis emphasizes the multi-omic, immunometabolic, and therapeutic dimensions of the pancreatic cancer-microbiome interface, where metagenomic, transcriptomic, metabolomic, and immunomic layers converge to shape tumor evolution and therapeutic response, advancing the vision of microbiome-informed precision oncology.\n                  <\/jats:p>","DOI":"10.3389\/fmed.2026.1737582","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T06:46:48Z","timestamp":1769150808000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Decoding the microbial blueprint of pancreatic cancer"],"prefix":"10.3389","volume":"13","author":[{"given":"Jhommara","family":"Bautista","sequence":"first","affiliation":[{"name":"Cancer Research Group (CRG), Faculty of Medicine, Universidad de Las Am\u00e9ricas","place":["Quito, Ecuador"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Bed\u00f3n-Galarza","sequence":"additional","affiliation":[{"name":"Servicio de Medicina Interna, Hospital General Docente de Calder\u00f3n","place":["Quito, Ecuador"]},{"name":"Facultad de Ciencias M\u00e9dicas, Universidad Central del Ecuador","place":["Quito, Ecuador"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Mart\u00ednez-Hidalgo","sequence":"additional","affiliation":[{"name":"Cancer Research Group (CRG), Faculty of Medicine, Universidad de Las Am\u00e9ricas","place":["Quito, Ecuador"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Masache-Cruz","sequence":"additional","affiliation":[{"name":"Cancer Research Group (CRG), Faculty of Medicine, Universidad de Las Am\u00e9ricas","place":["Quito, Ecuador"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Ben\u00edtez-N\u00fa\u00f1ez","sequence":"additional","affiliation":[{"name":"Cancer Research Group (CRG), Faculty of Medicine, Universidad de Las Am\u00e9ricas","place":["Quito, Ecuador"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila","family":"Valencia-Arroyo","sequence":"additional","affiliation":[{"name":"Cancer Research Group (CRG), Faculty of Medicine, Universidad de Las Am\u00e9ricas","place":["Quito, Ecuador"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s","family":"L\u00f3pez-Cort\u00e9s","sequence":"additional","affiliation":[{"name":"Cancer Research Group (CRG), Faculty of Medicine, Universidad de Las Am\u00e9ricas","place":["Quito, Ecuador"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"4298","DOI":"10.3748\/wjg.v27.i27.4298","article-title":"Pancreatic cancer: a review of epidemiology, trend, and risk factors.","volume":"27","author":"Hu","year":"2021","journal-title":"World J Gastroenterol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.cell.2023.02.014","article-title":"Pancreatic cancer: advances and challenges.","volume":"186","author":"Halbrook","year":"2023","journal-title":"Cell"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e70318","DOI":"10.1002\/cam4.70318","article-title":"Global trend in pancreatic cancer prevalence rates through 2040: an illness-death modeling study.","volume":"13","author":"Hesami","year":"2040","journal-title":"Cancer Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.pan.2014.10.001","article-title":"Addressing the challenges of pancreatic cancer: future directions for improving outcomes.","volume":"15","author":"Hidalgo","year":"2015","journal-title":"Pancreatology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","article-title":"Cancer statistics, 2022.","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"B6","doi-asserted-by":"publisher","first-page":"7864","DOI":"10.3748\/wjg.v20.i24.7864","article-title":"Imaging diagnosis of pancreatic cancer: a state-of-the-art review.","volume":"20","author":"Lee","year":"2014","journal-title":"World J Gastroenterol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"S160","DOI":"10.1102\/1470-7330.2007.9010","article-title":"Pancreatic adenocarcinoma: diagnosis and staging using multidetector-row computed tomography (MDCT) and magnetic resonance imaging (MRI).","volume":"7","author":"Francis","year":"2007","journal-title":"Cancer Imaging."},{"key":"B8","doi-asserted-by":"publisher","first-page":"eadq3110","DOI":"10.1126\/scitranslmed.adq3110","article-title":"Early detection of pancreatic cancer by a high-throughput protease-activated nanosensor assay.","volume":"17","author":"Montoya Mira","year":"2025","journal-title":"Sci Transl Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41392-022-00974-4","article-title":"Microbiota in health and diseases.","volume":"7","author":"Hou","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1681824","DOI":"10.3389\/fmed.2025.1681824","article-title":"Microbiome influence in gastric cancer progression and therapeutic strategies.","volume":"12","author":"Bautista","year":"2025","journal-title":"Front Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1634251","DOI":"10.3389\/fcimb.2025.1634251","article-title":"The vaginal microbiome in HPV persistence and cervical cancer progression.","volume":"15","author":"Bautista","year":"2025","journal-title":"Front Cell Infect Microbiol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1654792","DOI":"10.3389\/fmed.2025.1654792","article-title":"Microbial signatures in metastatic cancer.","volume":"12","author":"Bautista","year":"2025","journal-title":"Front Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1632435","DOI":"10.3389\/fmicb.2025.1632435","article-title":"The human microbiome in clinical translation: from bench to bedside.","volume":"16","author":"Bautista","year":"2025","journal-title":"Front Microbiol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1673880","DOI":"10.3389\/fmed.2025.1673880","article-title":"The microbiome as a therapeutic co-driver in melanoma immuno-oncology.","volume":"12","author":"Bautista","year":"2025","journal-title":"Front Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1690498","DOI":"10.3389\/fmed.2025.1690498","article-title":"Reprogramming prostate cancer through the microbiome.","volume":"12","author":"Bautista","year":"2025","journal-title":"Front Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1056\/NEJMra1600266","article-title":"The human intestinal microbiome in health and disease.","volume":"375","author":"Lynch","year":"2016","journal-title":"N Engl J Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"113550","DOI":"10.1016\/j.isci.2025.113550","article-title":"Neurodegeneration rewires the tumor microenvironment via the neuro-immune-cancer axis.","volume":"28","author":"Bautista","year":"2025","journal-title":"iScience."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1697200","DOI":"10.3389\/fpsyt.2025.1697200","article-title":"The gut-brain-circadian axis in anxiety and depression: a critical review.","volume":"16","author":"Bautista","year":"2025","journal-title":"Front Psychiatry"},{"key":"B19","doi-asserted-by":"publisher","first-page":"673969","DOI":"10.3389\/fmicb.2021.673969","article-title":"Characterization of the genitourinary microbiome of 1,165 middle-aged and elderly healthy individuals.","volume":"12","author":"Qin","year":"2021","journal-title":"Front Microbiol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"17588359251324882","DOI":"10.1177\/17588359251324882","article-title":"The dual role of gut microbiota in pancreatic cancer: new insights into onset and treatment.","volume":"17","author":"Cheng","year":"2025","journal-title":"Ther Adv Med Oncol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1158\/2159-8290.CD-17-1134","article-title":"The pancreatic cancer microbiome promotes oncogenesis by induction of innate and adaptive immune suppression.","volume":"8","author":"Pushalkar","year":"2018","journal-title":"Cancer Discov"},{"key":"B22","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.cell.2019.07.008","article-title":"Tumor microbiome diversity and composition influence pancreatic cancer outcomes.","volume":"178","author":"Riquelme","year":"2019","journal-title":"Cell."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1126\/science.aah5043","article-title":"Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine.","volume":"357","author":"Geller","year":"2017","journal-title":"Science"},{"key":"B24","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/s41586-023-05728-y","article-title":"Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer.","volume":"615","author":"Tintelnot","year":"2023","journal-title":"Nature"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1592549","DOI":"10.3389\/fmicb.2025.1592549","article-title":"comprehensive multi-omics analysis uncovers the associations between gut microbiota and pancreatic cancer.","volume":"16","author":"Han","year":"2025","journal-title":"Front Microbiol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/s41591-025-03615-9","article-title":"Clinical translation of microbiome research.","volume":"31","author":"Gilbert","year":"2025","journal-title":"Nat Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1672780","DOI":"10.3389\/fmicb.2025.1672780","article-title":"Microbial beginnings: determinants and disruptions of the neonatal microbiome.","volume":"16","author":"Bautista","year":"2025","journal-title":"Front Microbiol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"101042","DOI":"10.1016\/j.lanmic.2024.101042","article-title":"Clinical implications of maternal multikingdom transmissions and early-life microbiota.","volume":"6","author":"Zeng","year":"2025","journal-title":"Lancet Microbe"},{"key":"B29","doi-asserted-by":"publisher","first-page":"617002","DOI":"10.3389\/fcimb.2021.617002","article-title":"Urinary microbiome: yin and Yang of the urinary tract.","volume":"11","author":"Perez-Carrasco","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1159\/000510979","article-title":"Oral microbiota and cancer development.","volume":"88","author":"Tuominen","year":"2021","journal-title":"Pathobiology"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e0066524","DOI":"10.1128\/msystems.00665-24","article-title":"The role of gut microbiome and its metabolites in pancreatitis.","volume":"9","author":"Pan","year":"2024","journal-title":"mSystems."},{"key":"B32","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41522-025-00786-8","article-title":"Gut microbiota shapes cancer immunotherapy responses.","volume":"11","author":"Lei","year":"2025","journal-title":"NPJ Biofilms Microbiomes"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1677481","DOI":"10.3389\/fcell.2025.1677481","article-title":"Deciphering organotropism reveals therapeutic targets in metastasis.","volume":"13","author":"Bautista","year":"2025","journal-title":"Front Cell Dev Biol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"16801","DOI":"10.1038\/s41598-019-53041-4","article-title":"Fecal microbiome signatures of pancreatic cancer patients.","volume":"9","author":"Half","year":"2019","journal-title":"Sci Rep"},{"key":"B35","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s10020-025-01166-w","article-title":"Role of the oral-gut microbiota axis in pancreatic cancer: a new perspective on tumor pathophysiology, diagnosis, and treatment.","volume":"31","author":"Guo","year":"2025","journal-title":"Mol Med"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1038\/s41396-023-01483-0","article-title":"Potential effects of gut microbiota on host cancers: focus on immunity, DNA damage, cellular pathways, and anticancer therapy.","volume":"17","author":"Sun","year":"2023","journal-title":"ISME J"},{"key":"B37","doi-asserted-by":"publisher","first-page":"872019","DOI":"10.3389\/fcimb.2022.872019","article-title":"Potential roles of the gut microbiota in pancreatic carcinogenesis and therapeutics.","volume":"12","author":"Yang","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2025.05.015","article-title":"The functions of gut microbiota-mediated bile acid metabolism in intestinal immunity.","author":"He","year":"2025","journal-title":"J Adv Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/s41698-024-00681-z","article-title":"Barriers and opportunities in pancreatic cancer immunotherapy.","volume":"8","author":"Ju","year":"2024","journal-title":"NPJ Precis Oncol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41392-024-01811-6","article-title":"Bile acid metabolism and signaling in health and disease: molecular mechanisms and therapeutic targets.","volume":"9","author":"Fleishman","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"B41","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.chom.2022.02.004","article-title":"Gut microbiota-derived bile acids in intestinal immunity, inflammation, and tumorigenesis.","volume":"30","author":"Cai","year":"2022","journal-title":"Cell Host Microbe"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1690279","DOI":"10.3389\/fimmu.2025.1690279","article-title":"The gut microbiota and its metabolites: novel therapeutic targets for inflammatory bowel disease.","volume":"16","author":"Shen","year":"2025","journal-title":"Front Immunol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1080\/08830185.2021.1954638","article-title":"Tryptophan metabolites modulate inflammatory bowel disease and colorectal cancer by affecting immune system.","volume":"41","author":"Ala","year":"2022","journal-title":"Int Rev Immunol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1016\/j.celrep.2018.03.131","article-title":"CSF1R+ macrophages sustain pancreatic tumor growth through T cell suppression and maintenance of key gene programs that define the squamous subtype.","volume":"23","author":"Candido","year":"2018","journal-title":"Cell Rep"},{"key":"B45","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41392-024-01743-1","article-title":"Microbiota-gut-brain axis and its therapeutic applications in neurodegenerative diseases.","volume":"9","author":"Loh","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1152\/physrev.00018.2018","article-title":"The microbiota-gut-brain axis.","volume":"99","author":"Cryan","year":"2019","journal-title":"Physiol Rev"},{"key":"B47","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.brainres.2018.03.015","article-title":"Neurotransmitter modulation by the gut microbiota.","volume":"1693","author":"Strandwitz","year":"2018","journal-title":"Brain Res."},{"key":"B48","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41579-020-0433-9","article-title":"Gut microbiota in human metabolic health and disease.","volume":"19","author":"Fan","year":"2021","journal-title":"Nat Rev Microbiol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41575-023-00840-w","article-title":"Therapeutic developments in pancreatic cancer.","volume":"21","author":"Hu","year":"2024","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"e59248","DOI":"10.7759\/cureus.59248","article-title":"The potential of fecal and urinary biomarkers for early detection of pancreatic ductal adenocarcinoma: a systematic review.","volume":"16","author":"Arif","year":"2024","journal-title":"Cureus"},{"key":"B51","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41537-023-00340-5","article-title":"Urinary exosomal microRNAs as predictive biomarkers for persistent psychotic-like experiences.","volume":"9","author":"Tomita","year":"2023","journal-title":"Schizophrenia"},{"key":"B52","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41392-023-01693-0","article-title":"Intratumoural microbiota: a new frontier in cancer development and therapy.","volume":"9","author":"Cao","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"B53","doi-asserted-by":"publisher","first-page":"459","DOI":"10.4251\/wjgo.v8.i5.459","article-title":"Urinary metabolites as noninvasive biomarkers of gastrointestinal diseases: a clinical review.","volume":"8","author":"Sarosiek","year":"2016","journal-title":"World J Gastrointest Oncol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"3716","DOI":"10.1038\/s41598-020-60616-z","article-title":"Integrated RNA and metabolite profiling of urine liquid biopsies for prostate cancer biomarker discovery.","volume":"10","author":"Lee","year":"2020","journal-title":"Sci Rep"},{"key":"B55","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s12885-022-09318-5","article-title":"Urinary metabolomics for discovering metabolic biomarkers of bladder cancer by UPLC-MS.","volume":"22","author":"Wang","year":"2022","journal-title":"BMC Cancer"},{"key":"B56","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.tig.2023.01.004","article-title":"Bridging biological cfDNA features and machine learning approaches.","volume":"39","author":"Moser","year":"2023","journal-title":"Trends Genet"},{"key":"B57","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s11033-025-10609-w","article-title":"Rewriting the urinary tract paradigm: the urobiome as a gatekeeper of host defense.","volume":"52","author":"Pastuszka","year":"2025","journal-title":"Mol Biol Rep"},{"key":"B58","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1128\/JCM.02876-13","article-title":"Urine is not sterile: use of enhanced urine culture techniques to detect resident bacterial flora in the adult female bladder.","volume":"52","author":"Hilt","year":"2014","journal-title":"J Clin Microbiol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"e218","DOI":"10.1128\/mBio.00218-20","article-title":"Advances in understanding the human urinary microbiome and its potential role in urinary tract infection.","volume":"11","author":"Neugent","year":"2020","journal-title":"mBio."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1016\/j.cmi.2022.08.010","article-title":"The urobiome in men and women: a clinical review.","volume":"29","author":"Roth","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"B61","doi-asserted-by":"publisher","first-page":"3606","DOI":"10.3390\/cancers17223606","article-title":"The microbiome and genitourinary cancers: a new frontier.","volume":"17","author":"Winslow","year":"2025","journal-title":"Cancers"},{"key":"B62","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/s41522-025-00844-1","article-title":"Urinary biochemical ecology reveals microbiome-metabolite interactions and metabolic markers of recurrent urinary tract infection.","volume":"11","author":"Neugent","year":"2025","journal-title":"NPJ Biofilms Microbiomes"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1699308","DOI":"10.3389\/fmicb.2025.1699308","article-title":"Deciphering the urinary microbiome and urological cancers: from correlation to mechanisms and treatment.","volume":"16","author":"Zheng","year":"2025","journal-title":"Front Microbiol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3390\/microorganisms13020315","article-title":"The urogenital system microbiota: Is it a new gamechanger in urogenital cancers?","volume":"13","author":"Ece","year":"2025","journal-title":"Microorganisms"},{"key":"B65","doi-asserted-by":"publisher","first-page":"452","DOI":"10.3390\/microorganisms13020452","article-title":"Could the microbial profiling of normal pancreatic tissue from healthy organ donors contribute to understanding the intratumoral microbiota signature in pancreatic ductal adenocarcinoma?","volume":"13","author":"Tavano","year":"2025","journal-title":"Microorganisms"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1521952","DOI":"10.3389\/fcimb.2025.1521952","article-title":"Microbiological colonization of the pancreatic tumor affects postoperative complications and outcome after pancreatic surgery.","volume":"15","author":"Biesel","year":"2025","journal-title":"Front Cell Infect Microbiol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"e0182025","DOI":"10.1128\/spectrum.01820-25","article-title":"Survival mechanism of pancreatic tumor bacteria and their ability to metabolize chemotherapy drugs.","volume":"13","author":"Khan","year":"2025","journal-title":"Microbiol Spectr"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.3390\/microorganisms11051240","article-title":"Microbiota regulates pancreatic cancer carcinogenesis through altered immune response.","volume":"11","author":"Chai","year":"2023","journal-title":"Microorganisms"},{"key":"B69","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12866-023-03166-4","article-title":"Microbiome as a biomarker and therapeutic target in pancreatic cancer.","volume":"24","author":"Pourali","year":"2024","journal-title":"BMC Microbiol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1093\/clinchem\/hvad186","article-title":"Contributions of the microbiome-derived metabolome for risk assessment and prognostication of pancreatic cancer.","volume":"70","author":"Le\u00f3n-Letelier","year":"2024","journal-title":"Clin Chem"},{"key":"B71","doi-asserted-by":"publisher","first-page":"170","DOI":"10.14218\/CSP.2024.00017","article-title":"Gut dysbiosis and fecal microbiota transplantation in pancreatic cancer: current status and perspectives.","volume":"3","author":"Hu","year":"2024","journal-title":"Cancer Screening and Prevention."},{"key":"B72","doi-asserted-by":"publisher","first-page":"740606","DOI":"10.3389\/fonc.2021.740606","article-title":"The microbiome tumor axis: How the microbiome could contribute to clonal heterogeneity and disease outcome in pancreatic cancer.","volume":"11","author":"Basu","year":"2021","journal-title":"Front Oncol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/s41585-018-0104-z","article-title":"Community profiling of the urinary microbiota: considerations for low-biomass samples.","volume":"15","author":"Karstens","year":"2018","journal-title":"Nat Rev Urol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"e0010525","DOI":"10.1128\/jb.00105-25","article-title":"The urinary microbiome: the next frontier of bacterial ecology.","volume":"207","author":"Reasoner","year":"2025","journal-title":"J Bacteriol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"108171","DOI":"10.1016\/j.compbiolchem.2024.108171","article-title":"Urinary biomarkers analysis as a diagnostic tool for early detection of pancreatic adenocarcinoma: molecular quantification approach.","volume":"112","author":"Samir","year":"2024","journal-title":"Comput Biol Chem"},{"key":"B76","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1159\/000546584","article-title":"Biomarkers for early detection of pancreatic cancer.","volume":"11","author":"Bengtsson","year":"2025","journal-title":"Visc Med."},{"key":"B77","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1002\/ijc.34287","article-title":"Urine biomarkers enable pancreatic cancer detection up to 2 years before diagnosis.","volume":"152","author":"Debernardi","year":"2023","journal-title":"Int J Cancer"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1450326","DOI":"10.3389\/fonc.2024.1450326","article-title":"Evaluation of urinary C-reactive protein as an early detection biomarker for pancreatic ductal adenocarcinoma.","volume":"14","author":"Ali","year":"2024","journal-title":"Front Oncol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"628","DOI":"10.3390\/diagnostics15050628","article-title":"Recent exploration of solid cancer biomarkers hidden within urine or blood exosomes that provide fundamental information for future cancer diagnostics.","volume":"15","author":"Hara","year":"2025","journal-title":"Diagnostics"},{"key":"B80","doi-asserted-by":"publisher","first-page":"102936","DOI":"10.1016\/j.eclinm.2024.102936","article-title":"A noninvasive urinary microRNA-based assay for the detection of pancreatic cancer from early to late stages: a case control study.","volume":"78","author":"Baba","year":"2024","journal-title":"EClinicalMedicine"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1038\/s41416-024-02794-5","article-title":"Early detection of pancreatic cancer by comprehensive serum miRNA sequencing with automated machine learning.","volume":"131","author":"Kawai","year":"2024","journal-title":"Br J Cancer"},{"key":"B82","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s44276-024-00116-z","article-title":"Serum laminin \u03b32 monomer as a novel diagnostic and prognostic marker for pancreatic ductal adenocarcinoma.","volume":"3","author":"Terashima","year":"2025","journal-title":"BJC Rep"},{"key":"B83","doi-asserted-by":"publisher","first-page":"3512","DOI":"10.1158\/1078-0432.CCR-14-2467","article-title":"Identification of a three-biomarker panel in urine for early detection of pancreatic adenocarcinoma.","volume":"21","author":"Radon","year":"2015","journal-title":"Clin Cancer Res"},{"key":"B84","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/ijos.2014.48","article-title":"The mucosal immune system in the oral cavity-an orchestra of T cell diversity.","volume":"6","author":"Wu","year":"2014","journal-title":"Int J Oral Sci"},{"key":"B85","doi-asserted-by":"publisher","first-page":"4712498","DOI":"10.1155\/2020\/4712498","article-title":"Characterization of oral microbiome and exploration of potential biomarkers in patients with pancreatic cancer.","volume":"2020","author":"Sun","year":"2020","journal-title":"Biomed Res Int"},{"key":"B86","doi-asserted-by":"publisher","first-page":"7679","DOI":"10.3748\/wjg.v26.i48.7679","article-title":"Oral microbiome and pancreatic cancer.","volume":"26","author":"Wei","year":"2020","journal-title":"World J Gastroenterol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s40168-022-01262-7","article-title":"The oral microbiome, pancreatic cancer and human diversity in the age of precision medicine.","volume":"10","author":"Herremans","year":"2022","journal-title":"Microbiome"},{"key":"B88","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1186\/s12967-025-06676-z","article-title":"Cross-cohort analysis identifies shared gut microbial signatures and validates microbial risk scores for colorectal cancer.","volume":"23","author":"Zhang","year":"2025","journal-title":"J Transl Med"},{"key":"B89","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s40168-021-01059-0","article-title":"Identifying biases and their potential solutions in human microbiome studies.","volume":"9","author":"Nearing","year":"2021","journal-title":"Microbiome"},{"key":"B90","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1136\/gutjnl-2016-312580","article-title":"Human oral microbiome and prospective risk for pancreatic cancer: a population-based nested case-control study.","volume":"67","author":"Fan","year":"2018","journal-title":"Gut"},{"key":"B91","doi-asserted-by":"publisher","first-page":"e0040825","DOI":"10.1128\/msystems.00408-25","article-title":"Impact of study design, contamination, and data characteristics on results and interpretation of microbiome studies.","volume":"10","author":"Agudelo","year":"2025","journal-title":"mSystems."},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiae378","article-title":"Planning and analyzing a low-biomass microbiome study: a data analysis perspective.","author":"Austin","year":"2024","journal-title":"J Infect Dis."},{"key":"B93","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.3748\/wjg.v23.i10.1899","article-title":"Microbiome and pancreatic cancer: a comprehensive topic review of literature.","volume":"23","author":"Ertz-Archambault","year":"2017","journal-title":"World J Gastroenterol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s40364-022-00381-5","article-title":"Intratumor microbiome in cancer progression: current developments, challenges and future trends.","volume":"10","author":"Liu","year":"2022","journal-title":"Biomark Res"},{"key":"B95","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.semcancer.2025.03.002","article-title":"The relationship of the microbiome, associated metabolites and the gut barrier with pancreatic cancer.","volume":"112","author":"Daniel","year":"2025","journal-title":"Semin Cancer Biol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12943-019-1008-0","article-title":"The microbiota and microbiome in pancreatic cancer: more influential than expected.","volume":"18","author":"Wei","year":"2019","journal-title":"Mol Cancer"},{"key":"B97","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1186\/s12943-025-02458-9","article-title":"Microbiome-metabolome interplay in pancreatic cancer progression: insights from multi-omics analysis.","volume":"24","author":"Luo","year":"2025","journal-title":"Mol Cancer"},{"key":"B98","doi-asserted-by":"publisher","first-page":"e0096224","DOI":"10.1128\/spectrum.00962-24","article-title":"Integrated analysis of microbiome and metabolome reveals signatures in PDAC tumorigenesis and prognosis.","volume":"12","author":"Fang","year":"2024","journal-title":"Microbiol Spectr"},{"key":"B99","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1038\/s42003-021-02557-5","article-title":"Tumor microbiome contributes to an aggressive phenotype in the basal-like subtype of pancreatic cancer.","volume":"4","author":"Guo","year":"2021","journal-title":"Commun Biol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/s41575-018-0013-x","article-title":"Microbiome promotes pancreatic cancer.","volume":"15","author":"Dickson","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"e2316579120","DOI":"10.1073\/pnas.2316579120","article-title":"Gut dysbiosis: ecological causes and causative effects on human disease.","volume":"120","author":"Winter","year":"2023","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B102","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/J.ENG.2017.01.008","article-title":"The human microbiota in health and disease.","volume":"3","author":"Wang","year":"2017","journal-title":"Engineering"},{"key":"B103","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.gpb.2017.06.002","article-title":"Human gut microbiota and gastrointestinal cancer.","volume":"16","author":"Meng","year":"2018","journal-title":"Genomics Proteomics Bioinformatics"},{"key":"B104","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.cdtm.2020.01.002","article-title":"Pancreatic ductal adenocarcinoma immune microenvironment and immunotherapy prospects.","volume":"6","author":"Li","year":"2020","journal-title":"Chronic Dis Transl Med"},{"key":"B105","doi-asserted-by":"publisher","first-page":"101395","DOI":"10.1016\/j.nantod.2022.101395","article-title":"Reverse intratumor bacteria-induced gemcitabine resistance with carbon nanozymes for enhanced tumor catalytic-chemo therapy.","volume":"43","author":"Xi","year":"2022","journal-title":"Nano Today"},{"key":"B106","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.mib.2014.11.013","article-title":"Fusobacterium nucleatum: a commensal-turned pathogen.","volume":"23","author":"Han","year":"2015","journal-title":"Curr Opin Microbiol"},{"key":"B107","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/s42003-024-06201-w","article-title":"Fusobacterium nucleatum infection modulates the transcriptome and epigenome of HCT116 colorectal cancer cells in an oxygen-dependent manner.","volume":"7","author":"Udayasuryan","year":"2024","journal-title":"Commun Biol"},{"key":"B108","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.1038\/s41598-025-86531-9","article-title":"Invasion of pancreatic ductal epithelial cells by Enterococcus faecalis is mediated by fibronectin and enterococcal fibronectin-binding protein A.","volume":"15","author":"Shimosaka","year":"2025","journal-title":"Sci Rep"},{"key":"B109","doi-asserted-by":"publisher","first-page":"835","DOI":"10.4251\/wjgo.v13.i8.835","article-title":"Helicobacter pylori infection and other bacteria in pancreatic cancer and autoimmune pancreatitis.","volume":"13","author":"Kunovsky","year":"2021","journal-title":"World J Gastrointest Oncol"},{"key":"B110","doi-asserted-by":"publisher","first-page":"174","DOI":"10.14740\/wjon1596","article-title":"The association between oral anaerobic bacteria and pancreatic cancer.","volume":"14","author":"Ogrendik","year":"2023","journal-title":"World J Oncol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"1434771","DOI":"10.3389\/fimmu.2024.1434771","article-title":"Unraveling the gut microbiome\u2019s contribution to pancreatic ductal adenocarcinoma: mechanistic insights and therapeutic perspectives.","volume":"15","author":"Tabrizi","year":"2024","journal-title":"Front Immunol"},{"key":"B112","doi-asserted-by":"publisher","first-page":"1526589","DOI":"10.3389\/fimmu.2025.1526589","article-title":"Implications of intratumoral microbiota in tumor metastasis: a special perspective of microorganisms in tumorigenesis and clinical therapeutics.","volume":"16","author":"Zhang","year":"2025","journal-title":"Front Immunol"},{"key":"B113","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41392-024-01848-7","article-title":"Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets.","volume":"9","author":"Zhang","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"B114","doi-asserted-by":"publisher","first-page":"R42","DOI":"10.1186\/gb-2012-13-6-r42","article-title":"Composition of the adult digestive tract bacterial microbiome based on seven mouth surfaces, tonsils, throat and stool samples.","volume":"13","author":"Segata","year":"2012","journal-title":"Genome Biol"},{"key":"B115","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1093\/annonc\/mdx019","article-title":"Periodontal disease, edentulism, and pancreatic cancer: a meta-analysis.","volume":"28","author":"Maisonneuve","year":"2017","journal-title":"Ann Oncol"},{"key":"B116","doi-asserted-by":"publisher","first-page":"5781","DOI":"10.1097\/JS9.0000000000001724","article-title":"Gut microbiome changes associated with chronic pancreatitis and pancreatic cancer: a systematic review and meta-analysis.","volume":"110","author":"Hong","year":"2024","journal-title":"Int J Surg"},{"key":"B117","doi-asserted-by":"publisher","first-page":"e0294049","DOI":"10.1371\/journal.pone.0294049","article-title":"Microbial profile in bile from pancreatic and extra-pancreatic biliary tract cancer.","volume":"19","author":"Di Carlo","year":"2024","journal-title":"PLoS One"},{"key":"B118","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1053\/j.gastro.2013.01.068","article-title":"The epidemiology of pancreatitis and pancreatic cancer.","volume":"144","author":"Yadav","year":"2013","journal-title":"Gastroenterology"},{"key":"B119","doi-asserted-by":"publisher","first-page":"850093","DOI":"10.3389\/fimmu.2022.850093","article-title":"The interplay between inflammation and stromal components in pancreatic cancer.","volume":"13","author":"Li","year":"2022","journal-title":"Front Immunol"},{"key":"B120","doi-asserted-by":"publisher","first-page":"5228","DOI":"10.1177\/0300060518800588","article-title":"Serum levels of IL-6, IL-8, and IL-10 are indicators of prognosis in pancreatic cancer.","volume":"46","author":"Feng","year":"2018","journal-title":"J Int Med Res"},{"key":"B121","doi-asserted-by":"publisher","first-page":"732192","DOI":"10.3389\/fcell.2021.732192","article-title":"Toll like receptors as sensors of the tumor microbial dysbiosis: implications in cancer progression.","volume":"9","author":"Le Noci","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B122","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.4014\/jmb.2208.08002","article-title":"The microbiome-immune axis therapeutic effects in cancer treatments.","volume":"32","author":"Son","year":"2022","journal-title":"J Microbiol Biotechnol"},{"key":"B123","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s10147-023-02317-x","article-title":"Clinical Practice Guidelines for Pancreatic Cancer 2022 from the Japan Pancreas Society: a synopsis.","volume":"28","author":"Okusaka","year":"2022","journal-title":"Int J Clin Oncol"},{"key":"B124","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1007\/s12672-024-01704-8","article-title":"Crosstalk between gut microbiota and cancer chemotherapy: current status and trends.","volume":"15","author":"Yang","year":"2024","journal-title":"Discov Oncol"},{"key":"B125","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41522-025-00678-x","article-title":"Gut microbiota as a new target for anticancer therapy: from mechanism to means of regulation.","volume":"11","author":"Sun","year":"2025","journal-title":"NPJ Biofilms Microbiomes"},{"key":"B126","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1002\/cac2.12597","article-title":"Beyond the Gut: the intratumoral microbiome\u2019s influence on tumorigenesis and treatment response.","volume":"44","author":"Zhang","year":"2024","journal-title":"Cancer Commun"},{"key":"B127","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.cell.2014.03.011","article-title":"Role of the microbiota in immunity and inflammation.","volume":"157","author":"Belkaid","year":"2014","journal-title":"Cell"},{"key":"B128","doi-asserted-by":"publisher","first-page":"1517959","DOI":"10.3389\/fimmu.2025.1517959","article-title":"Immunocytes in the tumor microenvironment: recent updates and interconnections.","volume":"16","author":"Yu","year":"2025","journal-title":"Front Immunol"},{"key":"B129","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12934-020-01330-3","article-title":"Type 2 diabetes induced microbiome dysbiosis is associated with therapy resistance in pancreatic adenocarcinoma.","volume":"19","author":"Kesh","year":"2020","journal-title":"Microb Cell Fact"},{"key":"B130","doi-asserted-by":"publisher","first-page":"6419","DOI":"10.3390\/jcm13216419","article-title":"Updates in immunotherapy for pancreatic cancer.","volume":"13","author":"Chick","year":"2024","journal-title":"J Clin Med"},{"key":"B131","doi-asserted-by":"publisher","first-page":"kaf024","DOI":"10.1093\/jncics\/pkaf024","article-title":"Antibiotic treatment and survival in patients with resected, early-stage pancreatic ductal adenocarcinoma receiving chemotherapy.","volume":"9","author":"Gong","year":"2025","journal-title":"JNCI Cancer Spectr"},{"key":"B132","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1634\/theoncologist.2019-0570","article-title":"Antibacterial use is associated with an increased risk of hematologic and gastrointestinal adverse events in patients treated with gemcitabine for stage IV pancreatic cancer.","volume":"25","author":"Corty","year":"2020","journal-title":"Oncologist"},{"key":"B133","doi-asserted-by":"publisher","first-page":"721","DOI":"10.3892\/ijo.2020.5096","article-title":"Probiotic-derived ferrichrome inhibits the growth of refractory pancreatic cancer cells.","volume":"57","author":"Kita","year":"2020","journal-title":"Int J Oncol"},{"key":"B134","doi-asserted-by":"publisher","first-page":"113163","DOI":"10.1016\/j.biopha.2022.113163","article-title":"Butyrate, a postbiotic of intestinal bacteria, affects pancreatic cancer and gemcitabine response in in vitro and in vivo models.","volume":"151","author":"Panebianco","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"B135","doi-asserted-by":"publisher","first-page":"1652047","DOI":"10.3389\/fcell.2025.1652047","article-title":"Reprogramming cancer immunity with next-generation combination therapies.","volume":"13","author":"Kyriakidis","year":"2025","journal-title":"Front Cell Dev Biol"},{"key":"B136","doi-asserted-by":"publisher","first-page":"1535955","DOI":"10.3389\/fimmu.2025.1535955","article-title":"Nervous system-gut microbiota-immune system axis: future directions for preventing tumor.","volume":"16","author":"Wang","year":"2025","journal-title":"Front Immunol"},{"key":"B137","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1007\/s00213-019-05224-0","article-title":"Microbiota and gut neuropeptides: a dual action of antimicrobial activity and neuroimmune response.","volume":"236","author":"Aresti Sanz","year":"2019","journal-title":"Psychopharmacology"},{"key":"B138","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1136\/gutjnl-2023-331012","article-title":"Absence of a pancreatic microbiome in intraductal papillary mucinous neoplasm.","volume":"73","author":"Pust","year":"2024","journal-title":"Gut"},{"key":"B139","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3390\/ijms26010140","article-title":"Low bacterial biomass in human pancreatic cancer and adjacent normal tissue.","volume":"26","author":"May","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B140","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1038\/s41564-025-02035-2","article-title":"Guidelines for preventing and reporting contamination in low-biomass microbiome studies.","volume":"10","author":"Fierer","year":"2025","journal-title":"Nat Microbiol"},{"key":"B141","doi-asserted-by":"publisher","first-page":"2374596","DOI":"10.1080\/19490976.2024.2374596","article-title":"Microbiome and pancreatic cancer: time to think about chemotherapy.","volume":"16","author":"de Castilhos","year":"2024","journal-title":"Gut Microbes"},{"key":"B142","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1097\/SLA.0000000000006299","article-title":"Comprehensive assessment of the intrinsic pancreatic microbiome.","volume":"282","author":"Eckhoff","year":"2025","journal-title":"Ann Surg"},{"key":"B143","doi-asserted-by":"publisher","first-page":"1543144","DOI":"10.3389\/frmbi.2025.1543144","article-title":"Obesity reprograms the normal pancreas and pancreatic cancer microbiome in mice and humans.","volume":"4","author":"da Cruz","year":"2025","journal-title":"Front Microbiom."},{"key":"B144","doi-asserted-by":"publisher","first-page":"bbaf176","DOI":"10.1093\/bib\/bbaf176","article-title":"Bioinformatic approaches to blood and tissue microbiome analyses: challenges and perspectives.","volume":"26","author":"Sirasani","year":"2025","journal-title":"Brief Bioinform"},{"key":"B145","doi-asserted-by":"publisher","first-page":"7668","DOI":"10.1038\/s41598-023-33489-1","article-title":"Shallow shotgun sequencing reduces technical variation in microbiome analysis.","volume":"13","author":"La Reau","year":"2023","journal-title":"Sci Rep"},{"key":"B146","doi-asserted-by":"publisher","first-page":"5418","DOI":"10.1038\/s41467-022-33071-9","article-title":"Batch effects removal for microbiome data via conditional quantile regression.","volume":"13","author":"Ling","year":"2022","journal-title":"Nat Commun"},{"key":"B147","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/s13059-025-03721-4","article-title":"Melody: meta-analysis of microbiome association studies for discovering generalizable microbial signatures.","volume":"26","author":"Wei","year":"2025","journal-title":"Genome Biol"},{"key":"B148","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1038\/s41591-025-03693-9","article-title":"Pooled analysis of 3,741 stool metagenomes from 18 cohorts for cross-stage and strain-level reproducible microbial biomarkers of colorectal cancer.","volume":"31","author":"Piccinno","year":"2025","journal-title":"Nat Med"},{"key":"B149","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/s41698-023-00455-z","article-title":"High-dimensional deconstruction of pancreatic cancer identifies tumor microenvironmental and developmental stemness features that predict survival.","volume":"7","author":"Storrs","year":"2023","journal-title":"NPJ Precis Oncol"},{"key":"B150","doi-asserted-by":"publisher","first-page":"7345","DOI":"10.1038\/s41467-025-62685-y","article-title":"Cell free RNA detection of pancreatic cancer in pre diagnostic high risk and symptomatic patients.","volume":"16","author":"Moore","year":"2025","journal-title":"Nat Commun"},{"key":"B151","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1158\/2767-9764.CRC-24-0167","article-title":"The noncoding mutational landscape of pancreatic cancer reveals recurrent somatic mutations in enhancer regions.","volume":"5","author":"Hayashi","year":"2025","journal-title":"Cancer Res Commun"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkaf1190","article-title":"GMrepo v3: a curated human gut microbiome database with expanded disease coverage and enhanced cross-dataset biomarker analysis.","author":"Liu","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"B153","doi-asserted-by":"publisher","first-page":"001203","DOI":"10.1099\/mgen.0.001203","article-title":"On the limits of 16S rRNA gene-based metagenome prediction and functional profiling.","volume":"10","author":"Matchado","year":"2024","journal-title":"Microb Genom"},{"key":"B154","doi-asserted-by":"publisher","first-page":"3584","DOI":"10.1158\/0008-5472.CAN-24-3629","article-title":"Challenges and opportunities in analyzing cancer-associated microbiomes.","volume":"85","author":"Chia","year":"2025","journal-title":"Cancer Res"},{"key":"B155","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1053\/j.gastro.2022.03.054","article-title":"Metagenomic identification of microbial signatures predicting pancreatic cancer from a multinational study.","volume":"163","author":"Nagata","year":"2022","journal-title":"Gastroenterology"},{"key":"B156","doi-asserted-by":"publisher","first-page":"e16394","DOI":"10.7717\/peerj.16394","article-title":"Comparative analysis of shotgun metagenomics and 16S rDNA sequencing of gut microbiota in migratory seagulls.","volume":"11","author":"Liao","year":"2023","journal-title":"PeerJ"},{"key":"B157","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12866-025-03887-8","article-title":"Comparative analysis of metagenomic next-generation sequencing for pathogenic identification in clinical body fluid samples.","volume":"25","author":"Sun","year":"2025","journal-title":"BMC Microbiol"},{"key":"B158","doi-asserted-by":"publisher","first-page":"16966","DOI":"10.1038\/s41598-025-00976-6","article-title":"Biliary microbiome profiling via 16 S rRNA amplicon sequencing in patients with cholangiocarcinoma, pancreatic carcinoma and choledocholithiasis.","volume":"15","author":"Mizutani","year":"2025","journal-title":"Sci Rep"},{"key":"B159","doi-asserted-by":"publisher","first-page":"3030","DOI":"10.1038\/s41598-021-82726-y","article-title":"Comparison between 16S rRNA and shotgun sequencing data for the taxonomic characterization of the gut microbiota.","volume":"11","author":"Durazzi","year":"2021","journal-title":"Sci Rep"},{"key":"B160","doi-asserted-by":"publisher","first-page":"100391","DOI":"10.1016\/j.crmeth.2022.100391","article-title":"Comprehensive evaluation of shotgun metagenomics, amplicon sequencing, and harmonization of these platforms for epidemiological studies.","volume":"3","author":"Usyk","year":"2023","journal-title":"Cell Rep Methods"},{"key":"B161","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/s41564-021-01030-7","article-title":"Multi-kingdom microbiota analyses identify bacterial-fungal interactions and biomarkers of colorectal cancer across cohorts.","volume":"7","author":"Liu","year":"2022","journal-title":"Nat Microbiol"},{"key":"B162","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/1755-0998.13713","article-title":"Shallow shotgun sequencing of the microbiome recapitulates 16S amplicon results and provides functional insights.","volume":"23","author":"Stothart","year":"2023","journal-title":"Mol Ecol Resour"},{"key":"B163","doi-asserted-by":"publisher","first-page":"2205386","DOI":"10.1080\/19490976.2023.2205386","article-title":"Performance of gut microbiome as an independent diagnostic tool for 20 diseases: cross-cohort validation of machine-learning classifiers.","volume":"15","author":"Li","year":"2023","journal-title":"Gut Microbes"},{"key":"B164","doi-asserted-by":"publisher","first-page":"1691172","DOI":"10.3389\/fendo.2025.1691172","article-title":"Chronobiome medicine: circadian regulation of host-microbiota crosstalk in systemic physiology.","volume":"16","author":"Bautista","year":"2025","journal-title":"Front Endocrinol"},{"key":"B165","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1007\/s00253-025-13570-7","article-title":"Bidirectional interactions between circadian rhythms and the gut microbiome.","volume":"109","author":"Bautista","year":"2025","journal-title":"Appl Microbiol Biotechnol"},{"key":"B166","doi-asserted-by":"publisher","first-page":"1606242","DOI":"10.3389\/fendo.2025.1606242","article-title":"Peripheral clocks and systemic zeitgeber interactions: from molecular mechanisms to circadian precision medicine.","volume":"16","author":"Bautista","year":"2025","journal-title":"Front Endocrinol"},{"key":"B167","doi-asserted-by":"publisher","first-page":"14198","DOI":"10.1038\/s41598-023-39401-1","article-title":"Integrated multi-omics analysis reveals the molecular interplay between circadian clocks and cancer pathogenesis.","volume":"13","author":"P\u00e9rez-Villa","year":"2023","journal-title":"Sci Rep"},{"key":"B168","doi-asserted-by":"publisher","first-page":"1617198","DOI":"10.3389\/fcimb.2025.1617198","article-title":"Oncogenic viruses rewire the epigenome in human cancer.","volume":"15","author":"Bautista","year":"2025","journal-title":"Front Cell Infect Microbiol"},{"key":"B169","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/j.ccell.2022.09.009","article-title":"Tumor microbiome links cellular programs and immunity in pancreatic cancer.","volume":"40","author":"Ghaddar","year":"2022","journal-title":"Cancer Cell."},{"key":"B170","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/s41586-022-05435-0","article-title":"Effect of the intratumoral microbiota on spatial and cellular heterogeneity in cancer.","volume":"611","author":"Galeano Ni\u00f1o","year":"2022","journal-title":"Nature"},{"key":"B171","doi-asserted-by":"publisher","first-page":"e0160723","DOI":"10.1128\/mbio.01607-23","article-title":"Major data analysis errors invalidate cancer microbiome findings.","volume":"14","author":"Gihawi","year":"2023","journal-title":"mBio."},{"key":"B172","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13036-023-00340-0","article-title":"Automated classification of urine biomarkers to diagnose pancreatic cancer using 1-D convolutional neural networks.","volume":"17","author":"Karar","year":"2023","journal-title":"J Biol Eng"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1737582\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T06:46:50Z","timestamp":1769150810000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1737582\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,23]]},"references-count":172,"alternative-id":["10.3389\/fmed.2026.1737582"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1737582","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,23]]},"article-number":"1737582"}}